Page URL:

Hannah Flynn

Science Editor

Hannah Flynn is Science Editor at BioNews and at the charity that publishes it, the Progress Educational Trust (PET). She also works for Medical News Today as a fact checker, and for the NHS campaign Keep Our NHS Public. Together with her fellow BioNews editors Dr Joanne Delange and Jen Willows, she runs the BioNews writing scheme, which provides practical science writing training and experience for PhD students.

Hannah has been a health journalist for a decade and has worked as a reporter for Chemist+Druggist and the Nursing Standard, covering policy and clinical news. Bylines include various trade publications as well as Vice, Ars Technica, TES and the Guardian. She has also worked with charities and non-profit organisations including the Royal National Institute of Blind People, the Children's Society, the Institute of Physics and the National Council for Voluntary Organisations. She originally studied Biology at the University of Manchester, and went on to study journalism at Cardiff University.

BioNews News articles written by Hannah Flynn:
Page 1 of 1
COVID-19 genomic surveillance data tells story of pandemic in England
18 October 2021 - by Hannah Flynn
Genomic surveillance of the COVID-19 epidemic in England has cast light how different variants of SARS-CoV-2 spread in the population since autumn 2020... [Read More]
Huntington's gene found to affect development of two-week-old embryos
11 October 2021 - by Hannah Flynn
Researchers have discovered the earliest known effect of the Huntingtin gene variant which causes Huntington's disease... [Read More]
Embryonic stem cells used for cartilage regeneration
4 October 2021 - by Hannah Flynn
Scientists have described a method to create cartilage from human embryonic stem cells... [Read More]
Genetic testing advances revealed at European Human Genetics Conference
31 August 2021 - by Hannah Flynn
Genetic testing could prove useful for determining a diagnosis and prognosis for people with epilepsy, attendees at the European Society of Human Genetics conference heard... [Read More]
Dr Beverly Searle, CEO of charity Unique, to retire
23 August 2021 - by Hannah Flynn
Dr Beverly Searle, CEO of Unique, is retiring at the end of August, marking the end of more than 30 years of service to the charity for people with rare chromosomal conditions... [Read More]
Olaparib extends life of ovarian cancer patients with BRCA1/2
26 April 2021 - by Hannah Flynn
Cancer treatment olaparib has been shown to extend the life of relapsed ovarian cancer patients with mutations in BRCA1 and BRCA2, by nearly 13 months, when used as a maintenance therapy... [Read More]